Provider review
Jently review
Five different compounds carry exactly the same monthly price.
Compounds that differ this much do not converge on one figure by accident — what is priced is the plan, not the drug.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Jently
$124/mo semaglutide, $174/mo tirzepatide, five peptides at $119
- Vs median
- $45/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The interesting thing here is the shape of the price list rather than any single number in it. Five different compounds — two forms of NAD+, two of sermorelin, and glutathione — all carry exactly the same monthly figure. Things that differ this much in what they are and what they cost to produce do not land on one price by accident, so what is being priced is the plan and the service wrapped around it rather than the medication itself. That is genuinely useful to know before choosing between them: among those five, switching costs nothing at all, and the decision becomes a clinical one rather than a financial one. The two GLP-1 lines are priced separately and differ from each other, which is the ordinary pattern everywhere else. Everything published is a floor, introduced by as low as, with no upper rung anywhere on the site, and no milligram appears against any figure — so none of the seven prices can be attached to a quantity of anything.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are choosing between several peptides and want the cost to be identical across them
- You want a broad catalog priced on one visible basis
- You want both GLP-1 molecules available from the same provider
Look elsewhere if
- You want to know what a working dose costs. Every figure is a floor
- You expect the price to reflect the compound rather than the plan
- You want a dose behind the number
What it actually costs
Price as published
FIVE DIFFERENT PRODUCTS SHARE ONE PRICE: NAD+ injection, NAD+ nasal spray, sermorelin, sermorelin nasal spray and glutathione are each listed "As low as $119/mo" · the two GLP-1 lines are priced apart from that block — semaglutide "As low as $124/mo" and tirzepatide "As low as $174/mo" · ★ a single figure covering five unrelated compounds tells a reader something real: what is being priced is the plan and the service around it rather than the drug, so the cost of switching between those five is nothing and the cost of choosing between them is clinical rather than financial · every figure is "As low as", so all seven are floors with no rung above published · no milligram appears against any of them
- Vs median
- $45/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. FIVE UNRELATED COMPOUNDS AT ONE PRICE tells a reader what is being sold: the plan and the service, not the drug. Among those five, switching costs nothing and the choice is clinical rather than financial, which is genuinely useful to know. The GLP-1 lines are priced apart and differ, and every one of the seven figures is a floor with no rung above it. No low-dose product and no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- A broad catalog with every product priced on the same visible basis.
- Switching between the five same-priced compounds costs nothing.
- The two GLP-1 molecules are priced separately and clearly.
Pharmacy, labs and oversight
Jently does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Jently publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The interesting thing here is the shape of the price list rather than any single number in it. Five different compounds — two forms of NAD+, two of sermorelin, and glutathione — all carry exactly the same monthly figure. Compounds that differ this much in what they are and what they cost to make do not converge on one price by accident, so what is being priced is the plan and the service wrapped around it rather than the medication itself. That is useful to know before choosing: among those five, switching costs nothing and the decision is a clinical one rather than a financial one. The two GLP-1 lines are priced separately and differ from each other, which is the ordinary pattern. Everything published is a floor, introduced by as low as, with no upper rung anywhere, and no milligram appears against any figure, so none of the seven prices can be attached to a quantity.
The honest cons
Every figure is a floor, and no rung above any of them is published.
- Five unrelated compounds at one price means the drug is not what is being priced.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Jently is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#315 of 373
Ordered with the companies that pay us first, and Jently is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.